Skip to content

Noradrenergic modulation of learning noise in value-based decision making

Noradrenergic modulation of learning noise in value-based decision making - Norepinephrine and decision-making

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51201
Enrollment
60
Registered
2021-02-25
Start date
2021-05-10
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scientific investigation of healthy subjects healthy

Interventions

None listed

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy adult subjects with no history of neurological disorder/disease and no counter-indications to 3 Tesla MRI, EEG or to atomoxetine, and no personal relationship with the researchers will be included in this study. All participants will be right-handed with normal vision or contact lenses.

Exclusion criteria

Exclusion criteria: Significant history of head trauma, premature birth, learning disabilities, neurological or psychiatric illness. Heart arrhythmia, glaucoma, congenital eye diseases, hyperopia, myopia, hypertension and use of antidepressants or psychotropic medication and possible pregnancy (in adult females). MRI contra-indications, including metal implants and claustrophobia. Smoking more than five cigarettes a day - to avoid nicotine withdrawal effects during the study. Alcohol consumption

Design outcomes

Primary

MeasureTime frame
• Behavioural measures: choice history, outcome history, learning performance, choice reaction time, and choice variability • Computational measures: model fit, estimated model parameters and variables • Psychophysiological measures: task-related and task-unrelated changes in pupil size • Brain activity measures: effect of atomoxetine on task-related evoked BOLD or EEG signal

Secondary

MeasureTime frame
•Psychometric measures: state anxiety, trait anxiety, emotional arousal (to be included as regressors for behavioural, fMRI and EEG data) •Physiological measures: salivary cortisol and alpha amylase (to be included as regressors for behavioural, fMRI and EEG data)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)